---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-24-000005"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:20:02.568358+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Evolent reaffirms FY2023 guidance; announces two new contract wins

## Summary
- Reaffirmed previously issued revenue and Adjusted EBITDA guidance for Q4 and full year 2023.
- Secured new partner logo in the Southwest for its technology and services suite.
- Cross-sold NIA services to a legacy Evolent client in the Northeast.

## SEC filing metadata
- accession: 0001628908-24-000005
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890824000005/0001628908-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890824000005/evh-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-24-000005
- JSON: https://secwatch.observer/filing/0001628908-24-000005.json
- Plain text: https://secwatch.observer/filing/0001628908-24-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.